1. Field of the Invention
The present invention relates generally to medical devices and methods. More particularly, the present invention relates to the structure and deployment of a segmented stent at a luminal os at a branching point in the vasculature or elsewhere.
Maintaining the patency of body lumens is of interest in the treatment of a variety of diseases. Of particular interest in the to the present invention are the transluminal approaches to the treatment of body lumens. More particularly, the percutaneous treatment of atherosclerotic disease involving the coronary and peripheral arterial systems. Currently, percutaneous coronary interventions (PCI) involve a combination of balloon dilation along with the placement of an endovascular prosthesis commonly referred to as a stent. A major limitation of PCI/stent procedure is restenosis, i.e., the re-narrowing of a blockage after successful intervention typically occurring in the initial three to six months. The recent introduction of drug eluting stents (DES) has dramatically reduced the incidence of restenosis in coronary vascular applications and offers promise in peripheral stents, venous grafts, arterial and prosthetic grafts, as well as A-V fistulae. In addition to vascular applications, stents are being employed in treatment of other body lumens including the gastrointestinal systems (esophagus, large and small intestines, biliary system and pancreatic ducts) and the genital-urinary system (ureter, urethra, fallopian tubes, vas deferens).
While quite successful in treating arterial blockages and other conditions, most stent designs are challenged when used at a bifurcation in the blood vessel or other body lumen being treated. Presently, many different strategies are employed to treat bifurcation lesions with currently available stents all of which have major limitations.
One common approach is to place a conventional stent in the main or larger body lumen over the origin of the side branch. After removal of the stent delivery balloon, a second wire is introduced through a cell in the wall of the deployed stent and into the side branch. A balloon is then introduced into the side branch and inflated to enlarge the side-cell of the main vessel stent. This approach appears to work well when the side branch is relatively free of disease, although it is associated with increased rates of abrupt closure due to plaque shift as well as increased rates of late re-restenosis.
Another commonly employed strategy is the ‘kissing balloon’ technique in which separate balloons are positioned in the main and side branch vessels and simultaneously inflated. This technique is thought to prevent plaque shift.
Various two stent approaches including Culotte, T-Stent and Crush Stent techniques have been employed as well. When employing a T-stent approach, the operator deploys a stent in the side branch followed by placement of a main vessel stent. This approach is limited by anatomic variation (angle between main and side branch) and inaccuracy in stent positioning, which together can cause inadequate stent coverage of the os. More recently, the Crush approach has been introduced in which the side-vessel stent is deployed across the os with portions in both the main and side branch vessels. The main vessel stent is then delivered across the origin of the side branch and deployed, which results in crushing a portion of the side branch stent against the wall of the main vessel. Following main-vessel stent deployment, it is difficult and frequently not possible to re-enter the side branch after crush stenting. Unproven long-term results coupled with concern regarding the inability to re-enter the side branch and the impact of three layers of stent (which may be drug eluting) opposed against the main vessel wall has limited the adoption of this approach.
These limitations have led others to develop stents specifically designed to treat bifurcation lesions. One approach employs a stent design with a side opening for the branch vessel which is mounted on a specialized delivery balloon. The specialized balloon delivery system accommodates wires for both the main and side branch vessels. The system is tracked over both wires which provides a mean to axially and radially align the stent/stent delivery system. The specialized main vessel stent is then deployed and the stent delivery system removed while maintaining wire position in both the main and side branch vessels. The side branch is then addressed using kissing balloon or by delivering and an additional stent to the side branch. Though this approach has many theoretic advantages, it is limited by difficulties in tracking the delivery system over two wires (Vardi et al, U.S. Pat. Nos. 6,325,826 and 6,210,429).
For these reasons, it would be desirable to provide improved prostheses and methods for their placement to treat body lumens at or near the location of an os between a main body lumen and a side branch lumen, typically in the vasculature, and more particularly in the arterial vasculature. It would be further desirable if such prostheses and methods could treat the side branch vessels substantially completely in the region of the os and that the prostheses in the side branches be well-anchored at or near the os. At least some of these objectives will be met by the inventions described hereinbelow.
2. Description of the Background Art
Stent structures intended for treating bifurcated lesions are described in U.S. Pat. Nos. 6,599,316; 6,596,020; 6,325,826; and 6,210,429. Other stents and prostheses of interest are described in the following U.S. Pat. Nos. 4,994,071; 5,102,417; 5,342,387; 5,507,769; 5,575,817; 5,607,444; 5,609,627; 5,613,980; 5,669,924; 5,669,932; 5,720,735; 5,741,325; 5,749,825; 5,755,734; 5,755,735; 5,824,052; 5,827,320; 5,855,598; 5,860,998; 5,868,777; 5,893,887; 5,897,588; 5,906,640; 5,906,641; 5,967,971; 6,017,363; 6,033,434; 6,033,435; 6,048,361; 6,051,020; 6,056,775; 6,090,133; 6,096,073; 6,099,497; 6,099,560; 6,129,738; 6,165,195; 6,221,080; 6,221,098; 6,254,593; 6,258,116; 6,264,682; 6,346,089; 6,361,544; 6,383,213; 6,387,120; 6,409,750; 6,428,567; 6,436,104; 6,436,134; 6,440,165; 6,482,211; 6,508,836; 6,579,312; and 6,582,394;
The present invention provides improved prostheses and methods for their placement at an ostium (sometimes referred to herein as an os) opening from a main body lumen to a branch body lumen. The prostheses and methods will be principally useful in the vasculature, most typically the arterial vasculature, including coronary, peripheral, venous grafts, arterial and prosthetic grafts, as well as A-V fistulae. In addition to these vascular applications the present invention will also be useful in the treatment of other body lumens including the gastrointestinal systems (esophagus, large and small intestines, biliary system and pancreatic duets) and the genital-urinary system (ureter, urethra, fallopian tubes, vas deferens), and the like.
The prostheses of the present invention are particularly advantageous since they permit substantially complete coverage of the wall of the branch body lumen up to the lumen os. Additionally, the prostheses have integrated anchoring components which expandably conform to and at least partially circumscribe the wall of the main body vessel to selectively and stably position the prosthesis within the side branch lumen. The anchoring components may be fully expanded to open the luminal passage through the main branch lumen. Such complete opening is an advantage since it provides patency through the main branch lumen. Moreover, the open main branch lumen permits optional placement of a second prosthesis within the main branch lumen using conventional techniques.
In a first aspect of the present invention, a prosthesis comprises a radially expansible scaffold and at least two “circumferential” anchors extending axially from an end of the scaffold. The anchors are adapted to “expandably circumscribe” a portion of, usually at least one-half of the circumference main vessel wall at or near the os when the scaffold is implanted in the branch lumen with one end of the scaffold adjacent the os. By “expandably circumscribe,” it is meant that the anchors will extend into the main body lumen after initial placement of the scaffold within the branch body lumen. The circumferential anchors will be adapted to then be partially or fully radially expanded, typically by expansion of a balloon or other expandable element therein, so that the anchors deform outwardly and engage the interior of the main lumen wall.
The circumferential anchors will usually extend axially within the main vessel lumen for some distance after complete deployment. Thus, the contact between the anchors and the main vessel wall will usually extend both circumferentially (typically covering an arc equal to one-half or more of the circumference) and axially.
Expansion of the circumferential anchors at least partially within the main body lumen provides a generally continuous coverage of the os from the side body lumen to the main body lumen. Further and/or complete expansion of the circumferential anchors within the main body lumen may press the anchors firmly against the main body lumen wall and open up the anchors so that they do not obstruct flow through the main body lumen.
Usually, the prosthesis will include at least three circumferential anchors extending axially from the end of the scaffold. The prosthesis could include four, five, or even a greater number of circumferential anchors, but the use of three such anchors is presently preferred since a greater number could interfere with subsequent access by the second expansion balloon. The circumferential anchors will have an initial length (i.e., prior to radial expansion of the scaffold) which is at least 1.5 times the width of the scaffold prior to expansion, typically being at least 2 times the width, more typically being at least 5 times the width, and often being 7 times the width or greater. The lengths will typically be at least 2 mm, preferably being at least 3 mm, and more preferably being at least 6 mm, depending on the diameter of the scaffold and prosthesis. The circumferential anchors will usually have a width which is expandable to accommodate the expansion of the scaffold, and the anchors may be “hinged” at their point of connection to the scaffold to permit freedom to adapt to the geometry of the main vessel lumen as the prosthesis is expanded. It is also possible that the anchors could be attached to the single point to the scaffold, thus reducing the need for such expandability. The anchors may be congruent, i.e., have identical geometries and dimensions, or may have different geometries and/or dimensions. In particular, in some instances, it may be desirable to provide anchors having different lengths and/or different widths.
Often, radiopaque or other visible markers will be placed on the prostheses and/or delivery balloon at desired locations. In particular, it may be desirable to provide radiopaque markers at or near the location on the prosthesis where the scaffold is joined to the circumferential anchors. Such markers will allow a transition region of the prosthesis between the scaffold and the anchors to be properly located near the os prior to scaffold expansion. Note that it is also possible to provide the radiopaque or other markers on a balloon or other delivery catheter, where the markers would also be aligned with the transition region between the scaffold and the circumferential anchors.
In a second aspect of the present invention, a prosthesis is deployed across an os opening from the main body lumen to a branch body lumen. The prosthesis is positioned so that a scaffold of the prosthesis lies within the branch body lumen and at least two, typically at least three, circumferential anchors extend from the scaffold at the os into the main body lumen. The scaffold is radially expanded to implant the scaffold in the branch body lumen. While at least some of the anchors may initially obstruct the lumen, the anchors are subsequently circumferentially deformed (usually after expansion of the scaffold) to circumscribe at least a portion of the main vessel wall, with at lest one anchor typically covering at least 50% of the circumferential length, preferably at least 60% of the circumferential length and often at least 75% or greater. In this way, the circumferential anchors will open a passage through the anchors and the main body lumen to permit generally unobstructed blood flow or flow of other body fluids. Positioning of the prosthesis will usually comprise aligning a visible marker on at least one of the prosthesis and delivery balloon with the os so that the prosthesis is properly positioned relative to both the side branch lumen and the main body lumen.
In an exemplary deployment protocol, the scaffold is first expanded with a balloon catheter positioned within the scaffold. The balloon catheter expands the scaffold within the branch body lumen and usually begins separating and deploying the circumferential anchors within the main body lumen. After the scaffold has been deployed, the anchors are deformed to circumscribe the wall of the main body lumen, typically using a balloon positioned transversely through the anchors. In some instances, the scaffold and the circumferential anchors may be expanded and deformed using the same balloon, e.g., the balloon is first used to expand the anchor, partially withdrawn, and advanced traversely through the circumferential anchors where it is expanded for a second time. Alternatively, separate balloon catheters may be employed for expanding scaffold within the side branch and deforming the circumferential anchors within the main body lumen.
Optionally, a second prosthesis may be deployed within the passage formed through the circumferential anchors. For example, the second prosthesis may be deployed by a balloon catheter exchanged over a guidewire pre-positioned for deformation of the anchors. Alternatively, although less preferable, the anchors may be deformed by deployment of the second prosthesis in order to reduce the procedure by one step.
Referring to
The circumferential anchors 16 will usually extend axially from the scaffold section 12, as illustrated, but in some circumstances the anchors could extend helically, spirally, in a serpentine pattern, or other configurations. It is necessary, however, that the individual circumferential anchors be radially separable so that they can be independently folded, bent, and otherwise positioned within the main body lumen after the scaffold section 12 has been implanted within the branch body lumen. In the schematic embodiment of
In preferred embodiments, the circumferential anchors 16 will be attached to the scaffold section 12 such that they can both bend and rotate relative to an axis A thereof, as shown in broken line in
Referring now to
The scaffold section 52 is joined to the circumferential anchor section 54 at a plurality of points along a transition line 60. Individual circumferential anchors 62 each comprise four curving elements 66 which reduce in number to three and then to two in the axial direction away from the transition region 60. The particular structures shown permit radial expansion of the individual anchors as the scaffold is expanded. This is necessary since each circumferential anchor 62 is attached to three adjacent serpentine ring elements in the final serpentine ring 56. Thus, as these serpentine rings 56 are expanded, the circumferential anchor structures will also expand. It would be possible, of course, to join each of the circumferential anchors 62 only at a single location to the scaffold 52, thus allowing the anchors to be deployed without radial expansion.
The circumferential anchors 62 are curved and have a number of hinge regions which increase their conformability upon circumferential expansion by a balloon, as described hereinafter. Such conformability is highly desirable since the anchors will be expanded under a wide variety of differing conditions which will result in different final geometries for the anchors in use. The final configuration of the anchors in the main vessel lumen will depend on a number of factors, including length of the anchors and geometry of the vasculature and will vary greatly from deployment to deployment. While the anchors together will cover at least a portion of the main vessel wall circumference, most anchors will also be deformed to cover a significant axial length of the main vessel wall as well. Such coverage is schematically illustrated in the figures discussed below.
Referring now to
After catheter 30 is positioned so that the marker 20 is adjacent the os O, as shown in
In order to fully open the anchors 16, a second balloon catheter 130 is introduced over a guidewire GW to position the balloon 132 within the anchors, as shown in
The anchors 16 are deformed by inflation of the balloon 132 within the anchors 16, as shown in
When a second stent or prosthesis is deployed within the expanded anchor structure of the first prosthesis, the combination of the anchors and second stent both contribute to the support of the main vessel and os. In particular, the anchors are supported by the scaffold in the region of the os and over their lengths and tips by the deployed second stent.
While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
This application claims the benefit of U.S. Provisional Application No. 60/463,075, filed on Apr. 14, 2003, the full disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4950227 | Savin et al. | Aug 1990 | A |
4958634 | Jang | Sep 1990 | A |
4994071 | MacGregor | Feb 1991 | A |
5071406 | Jang | Dec 1991 | A |
5074845 | Miraki et al. | Dec 1991 | A |
5102417 | Palmaz | Apr 1992 | A |
5226889 | Sheiban | Jul 1993 | A |
5304132 | Jang | Apr 1994 | A |
5342387 | Summers | Aug 1994 | A |
5383892 | Cardon et al. | Jan 1995 | A |
5395333 | Brill | Mar 1995 | A |
5415635 | Bagaoisan et al. | May 1995 | A |
5507769 | Marin et al. | Apr 1996 | A |
5522882 | Gaterud et al. | Jun 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5575817 | Martin | Nov 1996 | A |
5593442 | Klein | Jan 1997 | A |
5607444 | Lam | Mar 1997 | A |
5609605 | Marshall et al. | Mar 1997 | A |
5609627 | Goicoechea et al. | Mar 1997 | A |
5613980 | Chauhan | Mar 1997 | A |
5632762 | Myler | May 1997 | A |
5645560 | Crocker et al. | Jul 1997 | A |
5656036 | Palmaz | Aug 1997 | A |
5658251 | Ressemann et al. | Aug 1997 | A |
5662608 | Imran et al. | Sep 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5669932 | Fischell et al. | Sep 1997 | A |
5713917 | Leonhardt et al. | Feb 1998 | A |
5718712 | Bonnal et al. | Feb 1998 | A |
5720724 | Ressemann et al. | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5741325 | Chaikof et al. | Apr 1998 | A |
5749825 | Fischell et al. | May 1998 | A |
5749851 | Wang | May 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5755735 | Richter et al. | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5788708 | Hegde et al. | Aug 1998 | A |
5810871 | Tuckey et al. | Sep 1998 | A |
5824052 | Khosravi et al. | Oct 1998 | A |
5827320 | Richter et al. | Oct 1998 | A |
5843116 | Crocker et al. | Dec 1998 | A |
5855598 | Pinchuk | Jan 1999 | A |
5860998 | Robinson et al. | Jan 1999 | A |
5868777 | Lam | Feb 1999 | A |
5868783 | Tower | Feb 1999 | A |
5893887 | Jayaraman | Apr 1999 | A |
5897588 | Hull et al. | Apr 1999 | A |
5906640 | Penn et al. | May 1999 | A |
5906641 | Thompson et al. | May 1999 | A |
5922019 | Hankh et al. | Jul 1999 | A |
5961546 | Robinson et al. | Oct 1999 | A |
5964771 | Beyar et al. | Oct 1999 | A |
5967971 | Bolser | Oct 1999 | A |
5980532 | Wang | Nov 1999 | A |
6004347 | McNamara et al. | Dec 1999 | A |
6017363 | Hojeibane | Jan 2000 | A |
6027486 | Crocker et al. | Feb 2000 | A |
6027517 | Crocker et al. | Feb 2000 | A |
6033434 | Borghi | Mar 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6048361 | Von Oepen | Apr 2000 | A |
6051020 | Goicoechea et al. | Apr 2000 | A |
6053913 | Tu et al. | Apr 2000 | A |
6053941 | Lindenberg et al. | Apr 2000 | A |
6056775 | Borghi et al. | May 2000 | A |
6056776 | Lau et al. | May 2000 | A |
6066155 | Amann et al. | May 2000 | A |
6066168 | Lau et al. | May 2000 | A |
6068654 | Berg et al. | May 2000 | A |
6068655 | Sequin et al. | May 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6090127 | Globerman | Jul 2000 | A |
6090133 | Richter et al. | Jul 2000 | A |
6096071 | Yadav | Aug 2000 | A |
6096073 | Webster et al. | Aug 2000 | A |
6099497 | Adams et al. | Aug 2000 | A |
6099560 | Penn et al. | Aug 2000 | A |
6120523 | Crocker et al. | Sep 2000 | A |
6127597 | Beyar et al. | Oct 2000 | A |
6129738 | Lashinski et al. | Oct 2000 | A |
6156052 | Richter et al. | Dec 2000 | A |
6159238 | Killion et al. | Dec 2000 | A |
6162243 | Gray et al. | Dec 2000 | A |
6165195 | Wilson et al. | Dec 2000 | A |
6168617 | Blaeser et al. | Jan 2001 | B1 |
6183509 | Dibie | Feb 2001 | B1 |
6206910 | Berry et al. | Mar 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6214036 | Letendre et al. | Apr 2001 | B1 |
6221080 | Power | Apr 2001 | B1 |
6221096 | Aiba et al. | Apr 2001 | B1 |
6221098 | Wilson et al. | Apr 2001 | B1 |
6231543 | Hegde et al. | May 2001 | B1 |
6241738 | Dereume | Jun 2001 | B1 |
6241744 | Imran et al. | Jun 2001 | B1 |
6254593 | Wilson | Jul 2001 | B1 |
6258116 | Hojeibane | Jul 2001 | B1 |
6261305 | Marotta et al. | Jul 2001 | B1 |
6261316 | Shaolian et al. | Jul 2001 | B1 |
6264682 | Wilson et al. | Jul 2001 | B1 |
6264686 | Rieu et al. | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6270525 | Letendre et al. | Aug 2001 | B1 |
6280412 | Pederson, Jr. et al. | Aug 2001 | B1 |
6287315 | Wijeratne et al. | Sep 2001 | B1 |
6287336 | Globerman et al. | Sep 2001 | B1 |
6290728 | Phelps et al. | Sep 2001 | B1 |
6293964 | Yadav | Sep 2001 | B1 |
6325826 | Vardi et al. | Dec 2001 | B1 |
6331186 | Wang et al. | Dec 2001 | B1 |
6344052 | Greenan et al. | Feb 2002 | B1 |
6346089 | Dibie | Feb 2002 | B1 |
6352551 | Wang | Mar 2002 | B1 |
6361544 | Wilson et al. | Mar 2002 | B1 |
6383212 | Durcan et al. | May 2002 | B2 |
6383213 | Wilson et al. | May 2002 | B2 |
6387120 | Wilson et al. | May 2002 | B2 |
6391032 | Blaeser et al. | May 2002 | B2 |
6395008 | Ellis et al. | May 2002 | B1 |
6402778 | Wang | Jun 2002 | B2 |
6409741 | Crocker et al. | Jun 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6409755 | Vrba | Jun 2002 | B1 |
6409757 | Trout, III et al. | Jun 2002 | B1 |
6428567 | Wilson et al. | Aug 2002 | B2 |
6436104 | Hojeibane | Aug 2002 | B2 |
6436134 | Richter et al. | Aug 2002 | B2 |
6440165 | Richter et al. | Aug 2002 | B1 |
6451050 | Rudakov et al. | Sep 2002 | B1 |
6478814 | Wang et al. | Nov 2002 | B2 |
6482211 | Choi | Nov 2002 | B1 |
6482227 | Solovay | Nov 2002 | B1 |
6488700 | Klumb et al. | Dec 2002 | B2 |
6508836 | Wilson et al. | Jan 2003 | B2 |
6517558 | Gittings et al. | Feb 2003 | B2 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6540779 | Richter et al. | Apr 2003 | B2 |
6547813 | Stiger et al. | Apr 2003 | B2 |
6554856 | Doorly et al. | Apr 2003 | B1 |
6562061 | Wang et al. | May 2003 | B1 |
6565597 | Fearnot et al. | May 2003 | B1 |
6572649 | Berry et al. | Jun 2003 | B2 |
6579312 | Wilson et al. | Jun 2003 | B2 |
6579314 | Lombardi et al. | Jun 2003 | B1 |
6582394 | Reiss et al. | Jun 2003 | B1 |
6589274 | Stiger et al. | Jul 2003 | B2 |
6596020 | Vardi et al. | Jul 2003 | B2 |
6599316 | Vardi et al. | Jul 2003 | B2 |
6607552 | Hanson | Aug 2003 | B1 |
6626934 | Blaeser et al. | Sep 2003 | B2 |
6637107 | Yasuhara et al. | Oct 2003 | B2 |
6652580 | Chuter et al. | Nov 2003 | B1 |
6656215 | Yanez et al. | Dec 2003 | B1 |
6656216 | Hossainy et al. | Dec 2003 | B1 |
6663665 | Shaolian et al. | Dec 2003 | B2 |
6663666 | Quiachon et al. | Dec 2003 | B1 |
6673104 | Barry | Jan 2004 | B2 |
6673106 | Mitelberg et al. | Jan 2004 | B2 |
6673107 | Brandt et al. | Jan 2004 | B1 |
6682557 | Quiachon et al. | Jan 2004 | B1 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6726714 | DiCaprio et al. | Apr 2004 | B2 |
6740113 | Vrba | May 2004 | B2 |
6756094 | Wang | Jun 2004 | B1 |
6764504 | Wang | Jul 2004 | B2 |
6770092 | Richter | Aug 2004 | B2 |
6790224 | Gerberding | Sep 2004 | B2 |
6805697 | Helm et al. | Oct 2004 | B1 |
6805702 | Chen et al. | Oct 2004 | B1 |
6824553 | Samson et al. | Nov 2004 | B1 |
6830575 | Stenzel et al. | Dec 2004 | B2 |
6843802 | Villalobos et al. | Jan 2005 | B1 |
6852116 | Leonhardt et al. | Feb 2005 | B2 |
6872215 | Crocker et al. | Mar 2005 | B2 |
6911038 | Mertens et al. | Jun 2005 | B2 |
6926690 | Renati | Aug 2005 | B2 |
20010008976 | Wang | Jul 2001 | A1 |
20010011188 | Berry et al. | Aug 2001 | A1 |
20010020181 | Layne | Sep 2001 | A1 |
20010023356 | Raz et al. | Sep 2001 | A1 |
20010037137 | Vardi et al. | Nov 2001 | A1 |
20010041930 | Globerman et al. | Nov 2001 | A1 |
20020058984 | Butaric et al. | May 2002 | A1 |
20020058993 | Landau et al. | May 2002 | A1 |
20020116047 | Vardi et al. | Aug 2002 | A1 |
20020156516 | Vardi et al. | Oct 2002 | A1 |
20020169498 | Kim et al. | Nov 2002 | A1 |
20020173840 | Brucker et al. | Nov 2002 | A1 |
20020183763 | Callol et al. | Dec 2002 | A1 |
20020183780 | Wang | Dec 2002 | A1 |
20020193862 | Mitelberg et al. | Dec 2002 | A1 |
20020193868 | Mitelberg et al. | Dec 2002 | A1 |
20020198559 | Mistry et al. | Dec 2002 | A1 |
20030083734 | Friedrich et al. | May 2003 | A1 |
20030097171 | Elliott | May 2003 | A1 |
20030114912 | Sequin et al. | Jun 2003 | A1 |
20030125797 | Chobotov et al. | Jul 2003 | A1 |
20030199967 | Hartley et al. | Oct 2003 | A1 |
20040015227 | Vardi et al. | Jan 2004 | A1 |
20040024441 | Bertolino et al. | Feb 2004 | A1 |
20040054362 | Lopath et al. | Mar 2004 | A1 |
20040054396 | Hartley et al. | Mar 2004 | A1 |
20040073250 | Pederson, Jr. et al. | Apr 2004 | A1 |
20040093058 | Cottone et al. | May 2004 | A1 |
20040106985 | Jang | Jun 2004 | A1 |
20040133268 | Davidson et al. | Jul 2004 | A1 |
20040138730 | Mitelberg et al. | Jul 2004 | A1 |
20040138737 | Davidson et al. | Jul 2004 | A1 |
20040143209 | Liu et al. | Jul 2004 | A1 |
20040158306 | Mitelberg et al. | Aug 2004 | A1 |
20040204754 | Kaplan et al. | Oct 2004 | A1 |
20040220655 | Swanson et al. | Nov 2004 | A1 |
20040249434 | Andreas et al. | Dec 2004 | A1 |
20040254627 | Thompson et al. | Dec 2004 | A1 |
20040260378 | Goshgarian | Dec 2004 | A1 |
20040260383 | Stelter et al. | Dec 2004 | A1 |
20050010278 | Vardi et al. | Jan 2005 | A1 |
20050015108 | Williams et al. | Jan 2005 | A1 |
20050049678 | Cocks et al. | Mar 2005 | A1 |
20050154447 | Goshgarian | Jul 2005 | A1 |
20050165469 | Hogendijk | Jul 2005 | A1 |
20050192656 | Eidenschink | Sep 2005 | A1 |
20050203563 | Pederson, Jr. et al. | Sep 2005 | A9 |
20050209674 | Kutscher et al. | Sep 2005 | A1 |
20050228483 | Kaplan et al. | Oct 2005 | A1 |
20050234536 | Mitelberg et al. | Oct 2005 | A1 |
20050251195 | Wang | Nov 2005 | A1 |
20050261722 | Crocker et al. | Nov 2005 | A1 |
20050288769 | Globerman | Dec 2005 | A1 |
20060025849 | Kaplan et al. | Feb 2006 | A1 |
20060079952 | Kaplan et al. | Apr 2006 | A1 |
20060116748 | Kaplan et al. | Jun 2006 | A1 |
20070203571 | Kaplan et al. | Aug 2007 | A1 |
20070213803 | Kaplan et al. | Sep 2007 | A1 |
20070213804 | Kaplan et al. | Sep 2007 | A1 |
20070276460 | Davis et al. | Nov 2007 | A1 |
20080015610 | Kaplan et al. | Jan 2008 | A1 |
20080015678 | Kaplan et al. | Jan 2008 | A1 |
20080183269 | Kaplan et al. | Jul 2008 | A2 |
Number | Date | Country |
---|---|---|
0712 614 | Nov 1995 | EP |
0 959 811 | May 1997 | EP |
0876 805 | May 1998 | EP |
1 433 441 | Nov 1999 | EP |
1 325 715 | Jan 2003 | EP |
1 325 716 | Jan 2003 | EP |
1 325 717 | Jan 2003 | EP |
1 362 564 | May 2003 | EP |
WO 9638101 | Dec 1996 | WO |
WO 9824503 | Jun 1998 | WO |
WO 0069367 | Nov 2000 | WO |
WO 0249538 | Jun 2002 | WO |
WO 2004026180 | Apr 2004 | WO |
WO 2004058100 | Jul 2004 | WO |
WO 2004089249 | Oct 2004 | WO |
WO 2004103217 | Dec 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20040204754 A1 | Oct 2004 | US |
Number | Date | Country | |
---|---|---|---|
60463075 | Apr 2003 | US |